321 SUMMER STREET, BOSTON, MA
Market cap: $258.2M (6/30/2025)
Price: $4.00
News, Articles of Incorporation, Bylaws
Announces Postponement of 2025 Annual Meeting of Stockholders
Changes in Board, Management or Compensation
Strengthens Enzyme Therapy Business with Acquisition
Reports First Quarter 2025 Financial Results and Provides Business Highlights
Annual Report to Security Holders
Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights
Investor Presentation
Q1
FY 2024
Q3
Q2
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
S-8 POS